Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity

Obesity Surgery

Volumn 14, Issue 8, 2004, Pages 1132-1134

  Higa Sansone, Guillermo ^a   Szomstein, Samuel ^a   Soto, Flavia ^a   Brasecsco, Oscar ^a   Cohen, Carlos ^b   Rosenthal, Raul J ^a  

^a Bariatric Institute   (United States)

^b DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Laparoscopic Roux en Y gastric bypass; Morbid obesity; Psoriasis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; MORBID OBESITY; MORBIDITY; PRIORITY JOURNAL; PSORIASIS; REMISSION; ROUX Y ANASTOMOSIS; SKIN DISEASE; STOMACH BYPASS;

ANASTOMOSIS, ROUX-EN-Y; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PSORIASIS; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 4644312879     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892041975569     Document Type: Article

References (22)

1. Raychaudhuri S. Psoriasis risk factors: role of lifestyle practices. Cutis 2000; 66: 348-52.
2. Granstein R. New treatments for psoriasis. N Engl J Med 2001; 345: 284-7.
3. Fitzpatrick TB, Arndt KA. Dermatology in General Medicine. New York: McGraw-Hill 1971: 219-31.
4. Little JW. Intraoral psoriasis associated with widespread dermal psoriasis. Intraoral Psoriasis 1976; 41: 174-81.
5. Elder JT, Henseler T. Of genes and antigens: the inheritance of psoriasis. J Invest Dermatol 1994; 103: S150-S153.
6. Farber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974; 148: 1-18.
7. Al'Abadie MS, Kent GG. The relationship between stress and the onset of exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
8. Fried RG, Friedman S. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995; 34: 101-5.
9. Gaston L, Lassonde M. Psoriasis and stress: a prospective study. J Am Acad Dermatol 1987; 17: 82-6.
10. Seville RH. Psoriasis and stress. Br J Dermatol 1977; 97: 297-302.
11. Vaupel R, Jerry H, Schlomer HT. Differential response of substance P-containing subtypes of adenomedullary cells to different stressors. Endocrinol 1998; 123: 2140-5.
12. Blalock JE, Bost KI, Smith ME. Neuroendocrine peptide hormones and their receptors in the immune system: production, processing, and action. J Neuroimmunol 1985; 10: 31-40.
13. Widermann CJ. Shared recognition molecules in the brain and lymphoid tissues: the polypeptide mediator network of psychoneuroimmunology. Immunol Lett 1987; 16: 371-8.
14. Raychaudhuri SP, Rein G, Farber EM. Neuropathogenesis and neuropharmacology of psoriasis. Int J Dermatol 1995; 34: 685-93.
15. Raychaudhuri SP, Farber EM. Are sensory nerves essential for the pathogenesis of psoriasis. J Am Acad Dermatol 1993; 28: 488-9.
16. Farber RM, Raychaudhuri SP. Concept of total care: a third dimension in the treatment of psoriasis. Cutis 1997; 59: 35-9.
17. Naldi L, Parazzini F, Peli L et al. Dietary factors and the risk of psoriasis: results of an Italian case control study. Br J Dermatol 1996; 134: S150-S153.
18. Mendez-Fernandez M. Koebner phenomenon: what you don't know may hurt you. Ann Plast Surg 2000; 44: 644-5.
19. Mohla G, Brodell R. Koebner phenomenon in psoriasis. Pearls in Dermatology 1999; 106: 39-40.
20. Buddeberg-Fischer B, Klaghofer R, Sigrist S et al. Impact of psychosocial stress and symptoms on indication for bariatric surgery and outcome in morbidly obese patients. Obes Surg 2004; 14: 361-9.
21. Boan J, Kolotkin RL, Westman EC et al. Binge eating, quality of life and physical activity improve after Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14: 341-8.
22. van Hout GCM, van Oudheusden I, van Heck GL. Psychological profile of morbidy obese. Obes Surg 2004; 14: 579-8.